The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma-Reference-Cited by-同舟云学术

The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma

Published:2023-12 Issue: Volume:67 Page:152219
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Estephan Fayez,Lap Coen J.,Banagan Jeff,Antonio Martha,Liu Shanshan,Diao Guoqing,Rozalen Alexandra Zara,Rajendran Rithika,Krasnow Steven,Subrahmanyam Ramesh,Nava Victor E.,Jain Maneesh

Funder

Prostate Cancer Foundation

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference43 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. Genomic testing in localized prostate cancer can identify subsets of African Americans with aggressive disease;Awasthi;J Natl Cancer Inst,2022

3. Racial disparities in prostate cancer: evaluation of diet, lifestyle, family history, and screening patterns;Hansen;Cancer Epidemiol Biomark Prev,2022

4. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor;Schechter;Science,1985

5. Receptor protein-tyrosine kinases and their signal transduction pathways;Geer;Annu Rev Cell Biol,1994

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13

2. Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy;Biomolecules and Biomedicine;2024-07-28

3. HER2-targeted therapies beyond breast cancer — an update;Nature Reviews Clinical Oncology;2024-07-22

4. Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition;2024-02-11